We continuously evolve our business to create a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs.
Novartis focuses its business on three leading divisions with strong innovation power and global scale: pharmaceuticals, eye care and generics. These three leading divisions are supported by our research organization.
We aim to develop innovative products in growing areas of healthcare. At the same time, we are expanding our presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.
